摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S)-N-[2-(aminomethyl)-5-chlorobenzyl]-4-[(2R)-2-hydroxy-3,3-dimethylbutanoyl]morpholine-3-carboxamide trifluoroacetate salt | 1462904-32-0

中文名称
——
中文别名
——
英文名称
(3S)-N-[2-(aminomethyl)-5-chlorobenzyl]-4-[(2R)-2-hydroxy-3,3-dimethylbutanoyl]morpholine-3-carboxamide trifluoroacetate salt
英文别名
(3S)-N-[[2-(aminomethyl)-5-chlorophenyl]methyl]-4-[(2R)-2-hydroxy-3,3-dimethylbutanoyl]morpholine-3-carboxamide;2,2,2-trifluoroacetic acid
(3S)-N-[2-(aminomethyl)-5-chlorobenzyl]-4-[(2R)-2-hydroxy-3,3-dimethylbutanoyl]morpholine-3-carboxamide trifluoroacetate salt化学式
CAS
1462904-32-0
化学式
C2HF3O2*C19H28ClN3O4
mdl
——
分子量
511.926
InChiKey
ORGCLDPWGSBROP-MOGJOVFKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.68
  • 重原子数:
    34.0
  • 可旋转键数:
    5.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    142.19
  • 氢给体数:
    4.0
  • 氢受体数:
    6.0

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] THROMBIN INHIBITORS<br/>[FR] INHIBITEURS DE THROMBINE
    申请人:MERCK SHARP & DOHME
    公开号:WO2013148478A1
    公开(公告)日:2013-10-03
    Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: (I) or a pharmaceutically acceptable salt thereof, wherein Q is CH2, NR4, O, S, S(O) or S(O2), wherein R4 is H, C1-6 alkyl, aryl, or C3-8 cycloalkyl; R1 is a heterocycle or -(CR5R6)1-2NH2, wherein R5 and R6, each time in which they occur, are independently H, C1-6 alkyl, -CH2F,-CHF2, CF3 or -CH2OH; R2 is OH, NH2 or NHSO2CH3; and R3 is C1-6 alkyl.
    本发明的化合物具有以下结构,可用于抑制凝血酶和相关的血栓闭塞,其中Q为CH2、NR4、O、S、S(O)或S(O2),其中R4为H、C1-6烷基、芳基或C3-8环烷基;R1为杂环或-(CR5R6)1-2NH2,其中R5和R6,在它们每次出现时,独立地为H、C1-6烷基、-CH2F、-CHF2、CF3或-CH2OH;R2为OH、NH2或NHSO2CH3;R3为C1-6烷基,或其药学上可接受的盐。
  • THROMBIN INHIBITORS
    申请人:Merck Sharp & Dohme Corp.
    公开号:US20150038498A1
    公开(公告)日:2015-02-05
    Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: (I) or a pharmaceutically acceptable salt thereof, wherein Q is CH 2 , NR 4 , O, S, S(O) or S(O 2 ), wherein R 4 is H, C 1-6 alkyl, aryl, or C 3-8 cycloalkyl; R 1 is a heterocycle or —(CR 5 R 6 )1-2NH2, wherein R 5 and R 6 , each time in which they occur, are independently H, C 1-6 alkyl, —CH 2 F, —CHF 2 , CF 3 or —CH 2 OH; R 2 is OH, NH 2 or NHSO 2 CH 3 ; and R 3 is C 1-6 alkyl.
    本发明的化合物具有以下结构(I)或其药学上可接受的盐,在抑制凝血酶和相关的血栓闭塞方面有用,其中Q为CH2,NR4,O,S,S(O)或S(O2),其中R4为H,C1-6烷基,芳基或C3-8环烷基;R1为杂环或-(CR5R6)1-2NH2,其中R5和R6在每次出现时独立地为H,C1-6烷基,-CH2F,-CHF2,CF3或-CH2OH;R2为OH,NH2或NHSO2CH3;R3为C1-6烷基。
  • Thrombin inhibitors
    申请人:Merck Sharp & Dohme Corp.
    公开号:US09133147B2
    公开(公告)日:2015-09-15
    Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof, wherein Q is CH2, NR4, O, S, S(O) or S(O2), wherein R4 is H, C1-6 alkyl, aryl, or C3-8 cycloalkyl; R1 is a heterocycle or —(CR5R6)1-2NH2, wherein R5 and R6, each time in which they occur, are independently H, C1-6 alkyl, —CH2F, —CHF2, CF3 or —CH2OH; R2 is OH, NH2 or NHSO2CH3; R3 is C1-6 alkyl.
    本发明的化合物在抑制凝血酶和相关血栓闭塞中有用,其结构如下:或其药学上可接受的盐,其中Q为CH2、NR4、O、S、S(O)或S(O2),其中R4为H、C1-6烷基、芳香族或C3-8环烷基;R1为杂环或-(CR5R6)1-2NH2,其中R5和R6,在它们出现的每个时候,独立地为H、C1-6烷基、-CH2F、-CHF2、CF3或-CH2OH;R2为OH、NH2或NHSO2CH3;R3为C1-6烷基。
  • US9133147B2
    申请人:——
    公开号:US9133147B2
    公开(公告)日:2015-09-15
  • Heterocyclic core analogs of a direct thrombin inhibitor
    作者:Timothy A. Blizzard、Sanjay Singh、Basanagoud Patil、Naresh Chidurala、Venukrishnan Komanduri、Samarpita Debnath、Sergei Belyakov、Alejandro Crespo、Alice Struck、Marc Kurtz、Judyann Wiltsie、Xun Shen、Lisa Sonatore、Marta Arocho、Dale Lewis、Martin Ogletree、Tesfaye Biftu
    DOI:10.1016/j.bmcl.2014.01.002
    日期:2014.2
    Thrombin is a serine protease that plays a key role in blood clotting. Pyrrolidine 1 is a potent thrombin inhibitor discovered at Merck several years ago. Seven analogs (2-8) of 1 in which the pyrrolidine core was replaced with various heterocycles were prepared and evaluated for activity against thrombin, clotting factors VIIa, IXa, Xa, and XIIa, and trypsin. The thiomorpholine analog 6 was the most active, essentially matching the thrombin inhibitory activity of 1 with slightly improved selectivity over trypsin. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物